Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Vitamin B-12 absorption studies combined, with and without intrinsic factor

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 78272 refers to a laboratory test known as Vitamin B-12 absorption studies, which are conducted both with and without intrinsic factor. This test is essential for measuring the absorption of Vitamin B-12, also known as cobalamin, which plays a critical role in several bodily functions, including the production of red blood cells (RBCs), the replication of DNA and RNA for cell development, and the proper functioning of the nervous system. The Vitamin B-12 absorption study is particularly useful in evaluating patients for conditions such as pernicious anemia, a type of anemia caused by the inability to absorb Vitamin B-12 due to a lack of intrinsic factor. The procedure involves administering an oral dose of Vitamin B-12 that is labeled with an isotope tracer, such as Cobalt 57 or Cobalt 58. This allows for the tracking of the Vitamin B-12 as it is absorbed through the gastrointestinal tract. The test is structured in stages, with the first stage (CPT® Code 78270) involving the administration of the labeled Vitamin B-12 followed by a 24-hour urine collection to measure the percentage of excreted labeled B-12, indicating the amount absorbed. If the results from the first stage are abnormal, a second stage (CPT® Code 78271) is performed, which includes the administration of intrinsic factor along with the labeled Vitamin B-12. CPT® Code 78272 is specifically utilized when the Schilling test is conducted using dual isotope tracers, allowing both stages of the test to be performed simultaneously. In this case, one isotope labels the Vitamin B-12 without intrinsic factor, while another labels the Vitamin B-12 with intrinsic factor. This dual approach enhances the efficiency of the testing process and provides comprehensive data regarding the absorption capabilities of the patient. The results are then analyzed, and a written report is generated by the physician, detailing the findings of the Vitamin B-12 absorption study.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The Vitamin B-12 absorption studies, represented by CPT® Code 78272, are indicated for the evaluation of various conditions related to Vitamin B-12 absorption. The following are the specific indications for performing this test:

  • Pernicious Anemia - This condition is characterized by the inability to absorb Vitamin B-12 due to a deficiency of intrinsic factor, which is necessary for the absorption process.
  • Intestinal Malabsorption - The test may be used to assess patients who exhibit symptoms of malabsorption, which can lead to deficiencies in essential nutrients, including Vitamin B-12.
  • Maldigestion - Conditions that impair the digestion of food can also affect the absorption of Vitamin B-12, making this test relevant for diagnosis.

2. Procedure

The procedure for the Vitamin B-12 absorption studies using CPT® Code 78272 involves several detailed steps to ensure accurate measurement of Vitamin B-12 absorption. The following outlines the procedural steps:

  • Step 1: Preparation - The patient is prepared for the test, which includes providing instructions on dietary restrictions prior to the test and ensuring that any medications that may interfere with the results are discussed with the healthcare provider.
  • Step 2: Administration of Vitamin B-12 - The patient is given an oral dose of Vitamin B-12 that is labeled with one isotope tracer, such as Cobalt 57 or Cobalt 58, without intrinsic factor. Simultaneously, a second oral dose of Vitamin B-12 labeled with a different isotope, which includes intrinsic factor, is also administered. This dual administration allows for a comprehensive assessment of absorption.
  • Step 3: Urine Collection - Following the ingestion of the labeled Vitamin B-12, a 24-hour urine collection is initiated. The patient collects all urine produced during this period to ensure that the sample accurately reflects the amount of Vitamin B-12 absorbed and excreted.
  • Step 4: Analysis - At the end of the 24-hour collection period, the urine sample is sent to the laboratory for analysis. The laboratory tests the sample to determine the percentage of bound Vitamin B-12 and free Vitamin B-12 that has been excreted, which provides insight into the absorption capabilities of the gastrointestinal tract.
  • Step 5: Interpretation - The physician interprets the results of the Vitamin B-12 absorption study, comparing the percentages of excreted labeled B-12 to assess whether absorption is normal or indicative of a deficiency or malabsorption issue. A written report detailing the findings is then provided.

3. Post-Procedure

After the completion of the Vitamin B-12 absorption studies, there are several considerations for post-procedure care. Patients may be advised to resume their normal activities and diet unless otherwise instructed by their healthcare provider. It is important for the physician to discuss the results of the test with the patient, explaining the implications of the findings and any necessary follow-up actions. If the test indicates malabsorption or a deficiency, further diagnostic testing or treatment options may be recommended to address the underlying condition. Patients should also be informed about any potential symptoms to monitor following the test, as well as the importance of follow-up appointments to ensure proper management of their health condition.

Short Descr VIT B-12 ABSORP COMBINED
Medium Descr VITAMIN B-12 ABSRPJ STDY W/WO INTRINSIC FACT
Long Descr Vitamin B-12 absorption studies combined, with and without intrinsic factor
Status Code Active Code
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 1 - Diagnostic Tests for Radiology Services
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Procedure or Service, Not Discounted when Multiple
Type of Service (TOS) 4 - Diagnostic Radiology
Berenson-Eggers TOS (BETOS) I1E - Standard imaging - nuclear medicine
MUE Not applicable/unspecified.
CCS Clinical Classification 209 - Radioisotope scan and function studies
Date
Action
Notes
2019-01-01 Deleted Code deleted
2013-01-01 Changed Medium Descriptor changed.
2011-01-01 Changed Short description changed.
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"